Table 5 Association of TLR4 and TLR9 haplotypes with cervical cancer risk.
From: Association of TLR4 and TLR9 polymorphisms and haplotypes with cervical cancer susceptibility
Haplotype | Case Frequency (%) | Control frequency (%) | OR (95%CI) | P value | |
|---|---|---|---|---|---|
Global P Value = 0.0033 | |||||
TLR4 | ACAC | 28.4 | 32.2 | 0.82 (0.55–1.24) | 0.395 |
GTAG | 14.2 | 11.2 | 1.32 (0.76–2.3) | 0.336 | |
GTAC | 15.9 | 9.7 | 1.77 (1.00–3.13) | 0.047 | |
GCAC | 8.7 | 12.4 | 0.67 (0.35–1.26) | 0.22 | |
GCAG | 5.7 | 13.6 | 0.39 (0.19–0.79) | 0.0076 | |
GCGC | 12.1 | 7 | 1.88 (1–3.51) | 0.0628 | |
Global P Value = 0.227 | |||||
TLR9 | GGTT | 28.4 | 34.5 | 0.75 (0.5–1.13) | 0.171 |
AATC | 29.7 | 25.2 | 1.25 (0.82–1.90) | 0.291 | |
AATT | 7 | 6.5 | 1.09 (0.52–2.30) | 0.816 | |
GATT | 7 | 6.1 | 1.16 (0.54–2.45) | 0.706 | |
AGTT | 6 | 6 | 0.99 (0.45–2.18) | 0.984 | |
GATC | 5 | 1.3 | 3.95 (1.15–13.50) | 0.019 | |
